FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101068 [Registered on: 14/01/2026] Trial Registered Prospectively
Last Modified On: 08/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Ayurvedic herbal Cap In High Blood Pressure Patients 
Scientific Title of Study   Randomized Controlled Clinical Study To Evaluate Add-On Effect of Polyherbal Ayurvedic Formulation (Cap.BPSolve) With Tab. Telmisartan In the Management Of Essential Hypertension 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Amruta Chandrakant Pacharne  
Designation  PG Scholar 
Affiliation  Siddhakala Ayurveda Mahavidyalaya , Sangmaner 
Address  OPD No 1 Kayachikitsa Department Siddhakala Ayurved mahavidyalaya pimp Arne road Sangma near Ahilyanagar Maharashtra 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  8378819533  
Fax    
Email  amrutapachrne@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Satish Digambar Urhe 
Designation  Associate Professor in Kayachikitsa  
Affiliation  Siddhakala Ayurveda Mahavidyalaya , Sangmaner 
Address  OPD No 1 Kayachikitsa Department Siddhakala Ayurved mahavidyalaya pimparne road Sangma near Ahilyanagar Maharashtra 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9890035901  
Fax    
Email  drsatishurhe9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Satish Digambar Urhe 
Designation  Associate Professor in Kayachikitsa  
Affiliation  Siddhakala Ayurveda Mahavidyalaya , Sangmaner 
Address  OPD No 1 Kayachikitsa Department Siddhakala Ayurved mahavidyalaya pimparne road Sangma near Ahilyanagar Maharashtra 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9890035901  
Fax    
Email  drsatishurhe9@gmail.com  
 
Source of Monetary or Material Support  
Siddhakala Ayurveda Mahavidyalaya ,Pimparne Road, Sangmaner Khurd, Sangmaner , Ahilyanagar, Maharashtra, India PIN code -422605 
 
Primary Sponsor  
Name  Amruta Chandrakant Pacharne  
Address  Siddhakala Ayurveda Mahavidyalaya ,Pimparne Road, Sangmaner Khurd, Sangmaner , Ahilyanagar, Maharashtra, India PIN code -422605 
Type of Sponsor  Other [Self ] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amruta Chandrakant Pacharne   Siddhakala Ayurved Mahavidyalaya And Hospital Sangamner  OPD NO 1 Department of Kayachikista
Ahmadnagar
MAHARASHTRA 
8378819533

amrutapachrne@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Board Of Ayurved Research And Statistics Committee Of Siddhakala Ayurved Mahavidyalay , Sangamner   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I10||Essential (primary) hypertension. Ayurveda Condition: VYANAVRUTAPRANAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Tab Telmisartan Tab.Telmisartan 40mg OD Orally,with water,Morning before meal,for 15 days
2Intervention ArmDrugOther than Classical(1) Medicine Name: Capsule BPSolve, Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: Lukewarm water), Additional Information: Capsule BPSolve will prepared using 06 herbal drugs as per GMP guidelines and will use orally after pilot study. Cap BPSolve will be given along with Tab Telmisartan
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Systolic Blood Pressure: less than 170 mm of Hg more than or equal to 140 mm of Hg.
Diastolic Blood Pressure: less than or equal to 110 mm of Hg More
than 90 mm of Hg.
Patient willing to participate in the research & to sign the written
informed consent form. 
 
ExclusionCriteria 
Details  Patient who has past history of atrial fibrillation, acute coronam syndrome, myocardial infarction, stroke or right ventricular hypertrophy, left ventricular hypertrophy, severe arrhythmia months.
Symptomatic patients with clinical features of early heart fai
Secondary hypertension.
Women who are pregnant and lactating or on estrogen rep therapy.
Alcoholics and drug abusers.
Accelerated and malignant hypertension. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To Assess Add-on effect of Polyherbal Ayurvedic Formulation (Cap.BPSolve) with Tab. Telmisartan on Systolic blood pressure (SBP), Diastolic blood pressure(DBP), Heart rate (HR) in reduction of Essential Hypertension  0th (baseline), 5 th , 10 th , 15 th day end of study with 5 days interval  
 
Secondary Outcome  
Outcome  TimePoints 
To Assess Add-on effect of Polyherbal Ayurvedic Formulation (Cap.BPSolve) with Tab. Telmisartan on other parameters like Headache, Giddiness, Fatigue, Palpitation, Insomnia etc.  0th (baseline), 5 th , 10 th , 15 th day end of study with 5 days interval 
 
Target Sample Size   Total Sample Size="160"
Sample Size from India="160" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   31/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This Study is a Randomised open labelled controlled clinical trial to compare the efficacy and add on effect of 6 herbal  Ayurvedic drug Formulation Cap BPSolve with Tab Telmisartan.
This study is  for 15 days in 160 Patients divided into 2 groups with Essential Hypertension and the effect on Systolic blood pressure ,Diastolic blood pressure, Heart-rate and other parameters like Headache, Fatigue ,Palpitation ,Insomnia , Giddiness etc
 
Close